Ecopetrol
EC
Petroleo Brasileiro SA Petrobras
PBR
Meritage Homes
MTH
KB Home
KBH
D.R. Horton
DHI
US Stock MarketDetailed Quotes
ACRV Acrivon Therapeutics
- 6.020
- +0.610+11.28%
Close Dec 31 16:00 ET
- 6.020
- 0.0000.00%
Post 16:00 ET
187.44MMarket Cap-2.26P/E (TTM)
6.150High5.500Low36.58KVolume5.500Open5.410Pre Close214.91KTurnover0.34%Turnover RatioLossP/E (Static)31.14MShares11.90052wk High0.95P/B65.31MFloat Cap3.19052wk Low--Dividend TTM10.85MShs Float25.470Historical High--Div YieldTTM12.02%Amplitude3.190Historical Low5.875Avg Price1Lot Size
Acrivon Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -76.66%-17.32M | -52.58%-13.9M | -50.42%-17.08M | -41.58%-42.64M | -32.20%-12.37M | -50.38%-9.81M | -56.46%-9.11M | -34.91%-11.36M | -115.40%-30.12M | -157.90%-9.35M |
| Net income from continuing operations | -55.13%-22.44M | -35.10%-18.8M | -29.24%-16.49M | -93.76%-60.39M | -115.61%-19.25M | -57.27%-14.47M | -139.07%-13.91M | -76.68%-12.76M | -91.88%-31.17M | -105.60%-8.93M |
| Depreciation and amortization | 88.72%251K | 76.74%228K | 79.20%224K | 47.25%536K | 19.20%149K | 14.66%133K | 65.38%129K | 177.78%125K | 883.78%364K | 861.54%125K |
| Other non cash items | 19.19%236K | 17.44%229K | 17.28%224K | 6.43%778K | 3.19%194K | 7.61%198K | 7.73%195K | 7.30%191K | -36.10%731K | -6.93%188K |
| Change In working capital | 17.42%2.16M | -23.01%1.97M | -786.51%-3.81M | 631.20%8.14M | 323.09%4.17M | -19.59%1.84M | 616.13%2.56M | 70.57%-430K | -567.07%-1.53M | -1,424.11%-1.87M |
| -Change in prepaid assets | 491.89%290K | -80.82%273K | -76.39%140K | 159.62%2.11M | 106.73%168K | -105.10%-74K | 188.28%1.42M | 167.08%593K | -363.22%-3.54M | -295.40%-2.5M |
| -Change in payables and accrued expense | 58.10%3.32M | 45.39%1.92M | -342.57%-3.75M | 153.63%6.78M | 423.63%4.21M | 107.52%2.1M | 3.28%1.32M | -101.43%-848K | 60.70%2.67M | -22.32%804K |
| -Change in other current liabilities | -45.86%-264K | -21.08%-224K | -13.71%-199K | -13.04%-754K | -21.02%-213K | -5.85%-181K | -12.80%-185K | -12.18%-175K | -16.61%-667K | 33.08%-176K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -76.66%-17.32M | -52.58%-13.9M | -50.42%-17.08M | -41.58%-42.64M | -32.20%-12.37M | -50.38%-9.81M | -56.46%-9.11M | -34.91%-11.36M | -115.40%-30.12M | -157.90%-9.35M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 956.13%16.01M | -555.29%-88.04M | -37.28%5.85M | 135.80%50.72M | 121.60%20.54M | 103.36%1.52M | 1,900.56%19.34M | 2,347.47%9.33M | -59,427.73%-141.68M | -69,291.97%-95.07M |
| Net PPE purchase and sale | ---989K | -22.32%-137K | -3,160.00%-815K | 40.54%-1.29M | -358.57%-1.15M | --0 | 89.57%-112K | 93.98%-25K | -810.08%-2.17M | -83.21%-251K |
| Net investment purchase and sale | 1,021.37%17M | -551.96%-87.91M | -28.73%6.67M | 137.28%52.01M | 122.87%21.69M | 103.39%1.52M | --19.45M | --9.35M | ---139.51M | ---94.82M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 956.13%16.01M | -555.29%-88.04M | -37.28%5.85M | 135.80%50.72M | 121.60%20.54M | 103.36%1.52M | 1,900.56%19.34M | 2,347.47%9.33M | -59,427.73%-141.68M | -69,291.97%-95.07M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -2,028.21%-1.5M | 32,446.17%123.35M | -172K | -101.53%-1.55M | -101.97%-2.01M | 155.71%78K | 379K | 0 | -9.37%101.71M | 2.11%101.86M |
| Net common stock issuance | --0 | ---- | ---- | --0 | --0 | --0 | ---- | ---- | --104.46M | ---- |
| Proceeds from stock option exercised by employees | --0 | 15,734.83%60.01M | --79K | 3,129.17%775K | --318K | 225.00%78K | --379K | --0 | 2,300.00%24K | --0 |
| Net other financing activities | ---1.5M | ---6.66M | ---251K | 16.01%-2.33M | ---- | ---- | ---- | ---- | ---2.77M | ---2.6M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -2,028.21%-1.5M | 32,446.17%123.35M | ---172K | -101.53%-1.55M | -101.97%-2.01M | 155.71%78K | 3,545.45%379K | --0 | -9.37%101.71M | 2.11%101.86M |
| Net cash flow | ||||||||||
| Beginning cash position | 20.65%46.43M | -10.23%25.02M | 21.81%36.43M | -70.09%29.91M | -6.77%30.27M | -54.32%38.48M | -69.42%27.88M | -70.09%29.91M | 4,924.67%99.99M | 711.29%32.47M |
| Current changes in cash | 65.71%-2.82M | 101.82%21.4M | -461.82%-11.41M | 109.31%6.52M | 340.49%6.16M | 84.14%-8.21M | 253.50%10.61M | 77.02%-2.03M | -171.51%-70.08M | -102.67%-2.56M |
| End cash Position | 44.07%43.61M | 20.65%46.43M | -10.23%25.02M | 21.81%36.43M | 21.81%36.43M | -6.77%30.27M | -54.32%38.48M | -69.42%27.88M | -70.09%29.91M | -70.09%29.91M |
| Free cash flow | -86.74%-18.31M | -52.21%-14.04M | -57.25%-17.9M | -36.07%-43.93M | -40.73%-13.52M | -41.15%-9.81M | -33.72%-9.22M | -28.86%-11.38M | -127.03%-32.28M | -155.18%-9.61M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
